BROUGHT TO YOU BY:

ETF Portfolio Builder

New

ETF Portfolio Builder

New

XLVIvsJDOCETF Comparison

ETF 1

XLVI

State Street Health Care Select Sector SPDR Premium Income Fund

This fund is part of

Options Strategies

-0.17%

Full XLVI fund page

VS

ETF 2

JDOC

JPMorgan Healthcare Leaders ETF

This fund is part of

Global Blended Cap

-0.27%

Full JDOC fund page

State Street Health Care Select Sector SPDR Premium Income Fund (XLVI) belongs to the Options Strategies segment. JPMorgan Healthcare Leaders ETF (JDOC) is part of the Global Blended Cap segment. Both ETFs have the same top 3 sector exposures: Healthcare and Consumer Non-Cyclicals. XLVI is less expensive with a Total Expense Ratio (TER) of 0.35%, versus 0.65% for JDOC. XLVI is up 5.2% year-to-date (YTD) with +$7M in YTD flows. JDOC performs worse with 5.17% YTD performance, and -$34K in YTD flows. Run a side-by-side ETF comparison of XLVI and JDOC below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios. Discover our library of Model portfolios

XLVI vs JDOC performance and flow charts

Performance

Cumulative Flows

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Data Services

Historic performance and flows

Data as of 07/22/2026

		1M	3M	YTD	1Y	3Y	5Y
Perf.	XLVI JDOC	+3.88%+4.47%	+7.81%+10.58%	+5.20%+5.17%	n/a+20.45%	n/an/a	n/an/a
Flows	XLVI JDOC	+$2M-	+$5M-$3M	+$7M-$34K	--$34K	--	--

Volatility and drawdown

		3M	1Y	3Y	5Y
Volatility	XLVI JDOC	+12.38%+17.36%	n/a+14.97%	n/an/a	n/an/a
Max drawdown	XLVI JDOC	-2.06%-3.99%	n/a-9.66%	n/an/a	n/an/a
Max drawdown duration	XLVI JDOC	7d19d	n/a154d	n/an/a	n/an/a

Trading data

Create an account to view trading data

Join for free

	XLVI	JDOC
Last sale 7/24/2026 at 1:30 PM	$26.52	$60.80
Previous close 07/23/2026	$26.33	$60.60
Consolidated volume 07/23/2026
Average volume 30 days
Average discount or premium 30 days
Average Bid/Ask spread 30 days

Main metrics

Last update 7/24/2026 at 1:30 PM

Live

Closed

	XLVI	JDOC
Last price	$26.52	$60.80
1D performance	+0.72%	+0.32%
AuM	$18.27 M	$9.13 M
E/R	0.35%	0.65%

Characteristics

	XLVI	JDOC
Management strategy	Active	Active
Provider	State Street Investment Management	J.P. Morgan Asset Management
Benchmark	-	-
N° of holdings	59	61
Asset class	-	-
Trailing 12m distribution yield	Join	Join
Inception date	July 30, 2025	November 1, 2023
ESG	No	No

More XLVI data on Trackinsight

More JDOC data on Trackinsight

Exposure

Countries

XLVI

USA

100.53%

Other

-0.53%

JDOC

USA

75.5%

Other

24.5%

Sectors

XLVI

Healthcare

100.33%

Other

-0.33%

JDOC

Healthcare

96.8%

Other

3.2%

Diversification

XLVI

Total weight of top 15 holdings out of 15

74.76%

JDOC

Total weight of top 15 holdings out of 15

60.84%

Top 15 holdings

Data as of June 30, 2026

XLVI

Eli Lilly & Co.

17.01%

Johnson & Johnson

10.96%

AbbVie, Inc.

7.97%

UnitedHealth Group, Inc.

6.77%

Merck & Co., Inc.

5.69%

Amgen, Inc.

3.50%

Thermo Fisher Scientific, Inc.

3.34%

Abbott Laboratories

2.83%

Gilead Sciences, Inc.

2.81%

Intuitive Surgical, Inc.

2.53%

Pfizer Inc.

2.46%

CVS Health Corp.

2.37%

Vertex Pharmaceuticals, Inc.

2.26%

Danaher Corp.

2.15%

Bristol Myers Squibb Co.

2.11%

JDOC

Eli Lilly & Co.

7.79%

AbbVie, Inc.

7.78%

UnitedHealth Group, Inc.

6.36%

Johnson & Johnson

4.83%

Merck & Co., Inc.

4.75%

AstraZeneca PLC

4.18%

Thermo Fisher Scientific, Inc.

3.36%

CVS Health Corp.

3.20%

Bristol Myers Squibb Co.

3.10%

Abbott Laboratories

2.81%

Roche Holding AG

2.73%

Novo Nordisk A/S

2.69%

GSK Plc

2.52%

argenx SE

2.50%

Intuitive Surgical, Inc.

2.24%

Frequently asked questions about XLVI and JDOC

How have the XLVI and JDOC ETFs performed in 2026?

As of July 22, 2026, XLVI is up 5.2% year-to-date (YTD), while JDOC has returned 5.17%. That puts XLVI better performer ahead so far this year.

Which ETF is attracting more investor money: XLVI or JDOC?

Year-to-date, the XLVI ETF saw +$7M in flows, compared to -$34K for JDOC.

Which ETF is bigger: XLVI or JDOC?

As of July 22, 2026, XLVI holds $18.27 M in assets under management (AUM), while JDOC manages $9.13 M.

What sectors do the XLVI and JDOC ETFs invest in?

XLVI leans toward sectors like Healthcare. Meanwhile, JDOC focuses on Healthcare.

What are the top holdings of the XLVI ETF and JDOC ETF?

XLVI top holdings include Eli Lilly & Co., Johnson & Johnson and AbbVie, Inc.. JDOC holds in its top three: Eli Lilly & Co., AbbVie, Inc. and UnitedHealth Group, Inc..

XLVIvsJDOCETF Comparison

State Street Health Care Select Sector SPDR Premium Income Fund

JPMorgan Healthcare Leaders ETF

XLVI vs JDOC performance and flow charts

Performance

Cumulative Flows

Get all the metrics on this page, and more, through a reliable ETF data feed

Countries

Sectors

Diversification

Top 15 holdings

How have the XLVI and JDOC ETFs performed in 2026?

As of July 22, 2026, XLVI is up 5.2% year-to-date (YTD), while JDOC has returned 5.17%. That puts XLVI better performer ahead so far this year.

Which ETF is attracting more investor money: XLVI or JDOC?

Year-to-date, the XLVI ETF saw +$7M in flows, compared to -$34K for JDOC.

Which ETF is bigger: XLVI or JDOC?

As of July 22, 2026, XLVI holds $18.27 M in assets under management (AUM), while JDOC manages $9.13 M.

What sectors do the XLVI and JDOC ETFs invest in?

XLVI leans toward sectors like Healthcare. Meanwhile, JDOC focuses on Healthcare.

What are the top holdings of the XLVI ETF and JDOC ETF?

XLVI top holdings include Eli Lilly & Co., Johnson & Johnson and AbbVie, Inc.. JDOC holds in its top three: Eli Lilly & Co., AbbVie, Inc. and UnitedHealth Group, Inc..

Which ETF is more diversified: XLVI or JDOC?

XLVI holds 59 securities with 74.76% of its assets in the top 15. JDOC has 61 securities and a top 15 weight of 60.84%.

Expert-Built ETF Portfolios, All in One Place